Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
暂无分享,去创建一个
J. Mega | E. Braunwald | E. Braunwald | S. Mohanavelu | C. Gibson | C. Gibson | E. Barnathan | A. Witkowski | P. Burton | L. Oppenheimer | V. Hricák | F. Misselwitz | JL Mega | R. Poulter | E. Barnathan | P. Bordes | V. Markov | Satishkumar Mohanavelu | C. Gibson